Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1166054

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1166054

Pharmaceutical Contract Sales Outsourcing [CSO] Market (Service: Personal Promotion, Non-personal Promotion, and Others) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

TMR's report on the pharmaceutical contract sales outsourcing (CSO) market in North America studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the pharmaceutical contract sales outsourcing (CSO) market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of pharmaceutical contract sales outsourcing (CSO) market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical contract sales outsourcing (CSO) market in North America.

The report delves into the competitive landscape of the pharmaceutical contract sales outsourcing (CSO) market. Key players operating in the pharmaceutical contract sales outsourcing (CSO) market in North America have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the pharmaceutical contract sales outsourcing (CSO) market profiled in this report.

Product Code: TMRGL772

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Industry Overview
  • 5.2. Impact of Sunshine Act on Contract Sales
  • 5.3. Regulatory Scenario
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Service

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Service, 2017-2031
    • 6.3.1. Personal Promotion
      • 6.3.1.1. Promotional Sales Team
        • 6.3.1.1.1. Dedicated Sales Team
        • 6.3.1.1.2. Syndicated Sales Team
      • 6.3.1.2. Key Account Management
      • 6.3.1.3. Vacancy Management
    • 6.3.2. Non-personal Promotion
      • 6.3.2.1. Tele-detailing
      • 6.3.2.2. Interactive E-Detailing
      • 6.3.2.3. Customer Service
      • 6.3.2.4. Medical Science Liaisons
      • 6.3.2.5. Patient Engagement Services
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Service

7. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Therapeutic Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Therapeutic Area, 2017-2031
    • 7.3.1. Cardiovascular Disorders
    • 7.3.2. Oncology
    • 7.3.3. Metabolic Disorders
    • 7.3.4. Neurology
    • 7.3.5. Orthopedic Diseases
    • 7.3.6. Infectious Diseases
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Competition Landscape

  • 8.1. Market Player - Competition Matrix (by tier and size of companies)
  • 8.2. Market Share Analysis, by Company, 2021
  • 8.3. Company Profiles
    • 8.3.1. Ashfield (UDG Healthcare plc)
      • 8.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.1.2. Company Financials
      • 8.3.1.3. Growth Strategies
      • 8.3.1.4. SWOT Analysis
    • 8.3.2. Granard Pharmaceutical Sales & Marketing
      • 8.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.2.2. Company Financials
      • 8.3.2.3. Growth Strategies
      • 8.3.2.4. SWOT Analysis
    • 8.3.3. Syneos Health
      • 8.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.3.2. Company Financials
      • 8.3.3.3. Growth Strategies
      • 8.3.3.4. SWOT Analysis
    • 8.3.4. Amplity Health
      • 8.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.4.2. Company Financials
      • 8.3.4.3. Growth Strategies
      • 8.3.4.4. SWOT Analysis
    • 8.3.5. IQVIA
      • 8.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.5.2. Company Financials
      • 8.3.5.3. Growth Strategies
      • 8.3.5.4. SWOT Analysis
    • 8.3.6. EVERSANA
      • 8.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.6.2. Company Financials
      • 8.3.6.3. Growth Strategies
      • 8.3.6.4. SWOT Analysis
Product Code: TMRGL772

List of Tables

  • Table 01: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 02: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031
  • Table 03: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031
  • Table 04: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Non-Personal Promotion, 2017-2031
  • Table 05: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 06: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 07: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031
  • Table 08: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031
  • Table 09: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Non-Personal Promotion, 2017-2031
  • Table 10: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 11: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 12: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031
  • Table 13: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031
  • Table 14: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017-2031
  • Table 15: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

List of Figures

  • Figure 01: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: North America Pharmaceutical Contract Sales Outsourcing[CSO] Market, by Service, 2021 and 2031
  • Figure 03: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 04: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Personal Promotion, 2017-2031
  • Figure 05: North America Pharmaceutical Contract Sales Outsourcing [CSO] (US$ Mn), by Non-personal Promotion, 2017-2031
  • Figure 06: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Others, 2017-2031
  • Figure 07: North America Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031
  • Figure 08: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
  • Figure 09: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Cardiovascular Disorders, 2017-2031
  • Figure 10: North America Pharmaceutical Contract Sales Outsourcing [CSO] (US$ Mn), by Oncology, 2017-2031
  • Figure 11: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Metabolic Disorders, 2017-2031
  • Figure 12: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Neurology, 2017-2031
  • Figure 13: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Orthopedic Diseases, 2017-2031
  • Figure 14: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Infectious Diseases, 2017-2031
  • Figure 15: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Others, 2017-2031
  • Figure 16: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 17: U.S. Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021 and 2031
  • Figure 18: U.S. Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 19: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Personal Promotion, 2017-2031
  • Figure 20: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Non-personal Promotion, 2017-2031
  • Figure 21: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017-2031
  • Figure 22: U.S. Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031
  • Figure 23: U.S. Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
  • Figure 24: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Cardiovascular Disorders, 2017-2031
  • Figure 25: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Oncology, 2017-2031
  • Figure 26: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Metabolic Disorders, 2017-2031
  • Figure 27: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Neurology, 2017-2031
  • Figure 28: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Orthopedic Diseases, 2017-2031
  • Figure 29: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Infectious Diseases, 2017-2031
  • Figure 30: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017-2031
  • Figure 31: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Canada Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021 and 2031
  • Figure 33: Canada Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 34: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Personal Promotion, 2017-2031
  • Figure 35: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Non-personal Promotion, 2017-2031
  • Figure 36: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017-2031
  • Figure 37: Canada Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031
  • Figure 38: Canada Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
  • Figure 39: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Cardiovascular Disorders, 2017-2031
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!